Navigation Links
Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
Date:8/21/2008

g prasugrel, there were 58 recurrent events compared with 115 recurrent events in the clopidogrel group.

-- The risk of cardiovascular death after a heart attack while on therapy was significantly reduced with prasugrel (3.7%) compared with clopidogrel (7.1%).

-- Diabetics treated with prasugrel showed a risk reduction of 60 percent in subsequent events (P=0.003).

-- Even after adjusting for variables such as age, gender, tobacco use and other health conditions, those taking prasugrel still showed a statistically significant reduction of 34 percent in recurrent events (P=0.024).

-- While recurrent bleeding events occurred infrequently among patients with at least one TIMI non-CABG major or minor bleeding (17 in the prasugrel group and 13 in the clopidogrel group), the analysis noted the high percentage of discontinuation following an initial major bleeding event, which were similar among those patients taking prasugrel (42%) and those taking clopidogrel (43%).

"Not only do multiple heart events increase healthcare costs due to additional hospitalizations, tests and physician visits, but they also result in higher morbidity for many patients," said Elliott Antman, M.D., director of the Samuel A. Levine Cardiac Unit at Brigham and Women's Hospital (BWH) in Boston and principal investigator with the BWH-based TIMI Study Group for the TRITON-TIMI 38 clinical trial.

Methodology

TRITON-TIMI 38 was a Phase III, randomized, double-blind, head-to-head clinical trial comparing the effects of prasugrel versus clopidogrel in patients with ACS who were managed with PCI, a procedure to open blockages in heart arteries, including the use of coronary stenting. The study enrolled 13,608 patients at 707 trial sites in 30 countries.

The primary endpoint of the study was to compare the effects of prasugrel to clopidogrel on the combined incidence of cardiovascular death, non-fatal heart attack or non-fatal stroke during a median p
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
2. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
5. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
6. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
7. febit and TGen Collaborate to Study New DNA Capture Method
8. Study Shows Benefits of a High Omega-3 Diet in Older Adults
9. NewCardio Announces Positive Results From Third Clinical Validation Study
10. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
11. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "North American Active Wound ... Application (Surgical Wound, & Ulcer), by End-User (In-Patient, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... is estimated to grow at a CAGR of ...
(Date:5/21/2015)... 2015 Research and ... addition of the "Arthroscopy Devices Markets ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of this ... world market for Arthroscopy Devices. The report ... the market for these products. , ,Product ...
(Date:5/21/2015)... CITY, Calif. , May 21, 2015  Cardica, Inc. ... 2015, new employee Greg Watson , the company,s vice ... shares of the company,s common stock, at a per share ... 20, 2015. The stock option was granted pursuant to Cardica, ... of directors in May 2015 under Rule 5653(c)(4) of the ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Cardica Announces New Employment Inducement Grant 2
... China, June 24, 2011 /PRNewswire-Asia/ -- High efficiency is the ... and how to save time is the key to high ... Shenzhen Wuzhou Changlian Trading Co., a trading company that manages ... help customers save great time and enjoy services. ...
... Janssen Products, LP, formerly Centocor Ortho Biotech ... PROCRIT® (Epoetin alfa) when used to treat anemia ... of a U.S. Food and Drug Administration (FDA)-approved ... The updates include modifications to the Boxed Warning, ...
Cached Medicine Technology:Have Body Check Anytime & Anywhere With Portable Products 2Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 2Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 3Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 4Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 5Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 6Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 7Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 8Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 9Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 10Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 11Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 12Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 13Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease 14
(Date:5/22/2015)... 2015 Hands On HealthCare Massage Therapy ... the Annual One Day Sale on Massage and ... HCMT offers drastically reduced certificates one day a year. This ... sessions, through what used to be the slowest time of ... community as well. This once a year occurrence has become ...
(Date:5/22/2015)... 22, 2015 Family, friends, students, colleagues, ... surgical oncologist, Dr. LaSalle D. Leffall, on Monday, May ... began after Grand Rounds in the hospital’s Tower Auditorium. ... outside the auditorium, trying to keep the secret. “I’d ... he sees me, he’ll know something is up,” she ...
(Date:5/22/2015)... 2015 Coordinating care for people ... Historically providers have not been reimbursed or rewarded ... 2015, Medicare has paved the way by offering ... the launch of Oculus Health , an ... using the platform will now be able to ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to a ... all generations are equally as likely to worry about what ... 75% Gen X, 77% Boomers, 69% Silent Generation), which may ... they are scared of aging, particularly Millennials (47%), Gen X’ers ... Harris Poll in April, 2015 among more than 2,000 U.S. ...
(Date:5/22/2015)... Coco Libre, the Official Coconut Water of Zappos.com Bay ... 104th running of the race. On Sunday, May 17, 2015, ... in one hour—one person about every 10 seconds. , ... the heart of the Bay Area, so unique, whimsical and ... finish line only made sense,” said Jennifer Goodrum, Coco Libre ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2
... (HealthDay News) -- Many uninsured and publicly insured trauma ... to the emergency department for routine follow-up care that ... study finds. These needs include minor issues such ... The researchers examined the medical records of 6,675 trauma ...
... using a home monitoring system with daily telemetry ... a safe alternative to conventional monitoring and could ... results of the ECOST study, a multicentre randomised ... cardioverter defibrillators has now become standard practice for ...
... Aug. 29, 2011The Echocardiography and Vascular Laboratory at ... to quality patient care and testing for heart and ... the Intersocietal Commission for the Accreditation of Echocardiography Laboratories ... that patients can rely on as an indication that ...
... , MONDAY, Aug. 29 (HealthDay News) -- Boxing ... encourage their kids to find sports that don,t focus ... Those are conclusions from the new policy statement from ... Society that recommends that pediatricians vigorously oppose children participating ...
... Imperial College London has identified six new genetic variants associated ... Nature Genetics, give scientists new leads in the ... treat this major disease. People of South Asian ancestry ... develop type 2 diabetes, which is a major risk factor ...
... finds that apixaban, a new anticoagulant drug, is superior ... systemic embolism in patients with atrial fibrillation. Moreover, ... in lower mortality. , The results were presented ... Society of Cardiology in Paris, France, today, and published ...
Cached Medicine News:Health News:Many Use ER for Routine Follow-Up Care After Hospital Discharge 2Health News:Remote ICD monitoring a 'safe alternative' to conventional follow up 2Health News:Pediatric Groups Want to KO Boxing for Kids 2Health News:Pediatric Groups Want to KO Boxing for Kids 3Health News:Six new genetic variants linked to type 2 diabetes discovered in South Asians 2Health News:Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives 2Health News:Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: